Zahra Jalili - Department of Medical Laser, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran
Sina Ghasemi - Lifestyle & Health Management Research Department, Academic Center for Education, Culture and Research, ACECR, Tehran, Iran
Mehrnoosh Nikpour - Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
Bahareh Haji Khani - Department of Microbiology,School of Medicine,Shahid Beheshti University of Medical Sciences,Tehran,Iran
Saba Sayari - Neonatal Health Research Center, Research Institute for Children&#۰۳۹;s Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Nooshin Nazarinejad - Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
Fatemeh Sameni - Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran

The novel coronavirus (۲۰۱۹-nCoV, or COVID-۱۹) was, for the first time, detected in Wuhan city (China) in ۲۰۱۹. It was subsequently spread worldwide which resulted in a viral pandemic associated with high rate of mortality. Although this virus mainly affects the pulmonary system, it has already been reported that COVID-۱۹ could also affect the nervous system, either at the first stages of disease or during the illness progress. During COVID-۱۹ pandemic, numerous neurological complications corresponding to Central Nervous System (CNS) disorders such as giddiness, headache, unconsciousness, encephalitis and ataxia, as well as Peripheral Nervous System (PNS) disturbances including Guillain-Barre syndrome (GBS), skeletal muscle malfunction, hyposmia, hypogeusia and muscle pain, were reported. In this regard, further researches about neurological manifestations of COVID-۱۹ is suggested. Current review attempts to discuss various CNS and PNS manifestations of SARS-CoV-۲ virosis.

COVID-۱۹, neurological manifestations, CNS, PNS, SARS-CoV-۲